Rose Bengal Test (RBT): How to Interpret It and When to Confirm

The Rose Bengal test (RBT) is a rapid slide agglutination test used to screen for brucellosis. A drop of the patient's serum is mixed with a buffered, Rose Bengal-stained Brucella abortus antigen suspension held at an acidic pH of about 3.65, and visible pink clumping within four minutes is a positive result. Its whole design is built around speed and low cost, which makes it well suited to small laboratories and field screening. But a positive RBT is a starting point, not a diagnosis: understanding what to do with the result, and its traps in endemic areas, is what this article is about.

Figure: Rose Bengal plate test

Procedure of Rose Bengal Plate Test

1. Bring the antigen and all sera to room temperature before starting. A cold antigen weakens agglutination and is a common cause of false-negative or weak reactions. Mix the antigen gently before use; do not shake it into a froth.
2. Place 0.03 ml (30 µL) of the patient's undiluted serum on a clean white tile or enamel plate.
3. Add an equal volume (0.03 ml) of the Rose Bengal-stained Brucella abortus antigen suspension next to the serum.
4. Mix the two with a clean stick or loop to produce an even zone about 2 cm in diameter, using a fresh stick for each sample to avoid carryover.
5. Rock the plate gently and continuously for four minutes at room temperature.
6. Read at exactly four minutes against a good light. Any visible pink granulation or clumping is a positive result; a smooth, uniform pink suspension is negative.
7. Discard the plate and sticks into disinfectant as biohazardous waste. Brucella is a hazard-group-3 organism, and even serum work should follow good containment practice.

Figure: Proposed use of RBT in the diagnosis of human brucellosis and complementary tests

Controls. Run a known positive serum and a known negative serum alongside each batch. The positive control must show clear agglutination and the negative control must remain smooth; if either fails, the antigen or technique is at fault and patient results should not be reported.

Why the antigen is held at acidic pH

The antigen is supplied as a dense, stained Brucella abortus cell suspension in a lactate or acetate buffer that holds it at a low pH, conventionally 3.65 ± 0.05. This acidic pH is not incidental, it is what makes the test specific.

At this low pH, the weak, low-avidity agglutination caused by non-specific and cross-reacting IgM, the kind that clumps antigen in many healthy or unrelated sera, is suppressed, so it does not produce false positives. At the same time, the acidic condition preserves, and can even enhance, the agglutinating activity of the high-avidity specific anti-Brucella antibodies (predominantly IgG and IgA) that indicate real exposure. The acid does not simply silence one antibody class; it filters out low-avidity binding and keeps high-avidity binding, which is why it works as a specificity filter.

This is also why the classic prozone problem is less prominent in RBT than in a neutral-pH agglutination test: at pH 3.65, the blocking-antibody effect that would otherwise mask a strong reaction is largely neutralized, so high-titer sera still agglutinate visibly. The acidic buffer, in short, is the built-in filter that lets a crude slide test achieve useful specificity.

One consequence follows directly from this design: because the acidic pH deliberately dampens IgM-mediated agglutination, RBT can be less sensitive in the earliest days of acute infection, when the antibody response is still largely IgM. This is part of why a negative RBT does not exclude very early brucellosis.

Interpretation

A positive RBT (any visible agglutination) indicates anti-Brucella antibodies are present, but it does not by itself confirm active brucellosis. Detectable agglutinins can come from past exposure, cross-reacting organisms, or vaccination in animals. A negative RBT makes brucellosis unlikely in a patient with a compatible illness, but does not exclude it, particularly in the first days of acute infection before antibodies have risen, or in some long-standing chronic cases.

When to confirm a positive

A positive result should be confirmed by a quantitative method before treatment is started. The standard agglutination test (SAT) provides a titer; the complement fixation test (CFT) or an IgG-specific ELISA add specificity. In endemic areas especially, treating on a single positive RBT risks unnecessary exposure to prolonged, potentially toxic antibiotic regimens.

Limitation of Rose Bengal Test

1. Low sensitivity particularly in long evolution (chronic) cases
2. Reduced specificity in endemic areas. Where brucellosis is common, many people carry residual anti-Brucella antibodies from past exposure, so a positive RBT more often reflects previous rather than active infection. Because of this, using unmodified RBT as a stand-alone screen in endemic areas produces large numbers of false positives, and a titrated or confirmed approach is preferred over acting on a single qualitative positive.
3. Use of this test as the sole determinant of active infection would lead to unnecessary treatment with potentially toxic agents.
4. Prozone effects are sometimes cited as a cause of strongly positive sera reading falsely negative. In practice, the acidic pH of the standard RBT largely suppresses prozones, and the definitive evaluations of the test report their near-absence. Where a strong clinical suspicion meets a negative or weak RBT, testing diluted serum or moving to a quantitative method resolves the question.

Positive samples should be checked by the complement fixation test (CFT) or by an IgG-specific procedure such as ELISA. The RBT can be used in all animal species but positive results should be confirmed by a quantitative test.

How to Remember

1. The acid is the filter. The pH 3.65 antigen is the test's built-in specificity control: acid silences the non-specific IgM agglutinins that cause false positives while keeping the real anti-Brucella antibodies active. If you remember that the acid filters out noise, you remember both why RBT works as a cheap screen and why it still needs confirmation for the noise it cannot filter (past exposure in endemic areas).
2. Positive screens, it doesn't diagnose. RBT is a doorway, not a destination. A positive opens the question; SAT/CFT/ELISA answer it. Treating on RBT alone, especially where brucellosis is endemic, means treating old antibodies as if they were active disease.

Key exam facts in one table

Where students get confused

"A positive Rose Bengal test means the patient has brucellosis." It means anti-Brucella antibodies are present. Those can come from active infection, past exposure, or cross-reaction. In endemic areas especially, a positive most often needs confirmation before it drives treatment.

"Why acidic pH? Isn't that harsh on the reaction?" The acid is the point. It suppresses the non-specific IgM agglutinins that would otherwise cause false positives, while leaving the specific anti-Brucella antibodies active. Without the acidic buffer, RBT would be far less specific.

"Prozone is a major limitation of RBT." Less than commonly taught. The acidic pH largely prevents prozone in the standard test. It is worth knowing as a theoretical caveat, but the definitive evaluations report prozones are nearly absent at pH 3.65.

"A negative RBT rules out brucellosis." Not in early acute infection, before antibodies rise, and not reliably in some chronic cases. A compatible clinical picture with a negative RBT still warrants a quantitative test.

References

1. Díaz, R., Casanova, A., Ariza, J., & Moriyón, I. (2011). The Rose Bengal test in human brucellosis: a neglected test for the diagnosis of a neglected disease. PLoS Neglected Tropical Diseases, 5(4), e950.
2. Davies, G. (1971). The Rose Bengal test. The Veterinary Record, 88(17), 447–449.
3. World Organisation for Animal Health (WOAH/OIE). Brucellosis (Brucella abortus, B. melitensis, B. suis): manual of diagnostic tests and vaccines.
4. Tille, P. M. (2022). Bailey & Scott's Diagnostic Microbiology (15th ed.). Elsevier.